We are live on ! Find out more
IVF

INVO Fertility Inc

10 hedge funds and large institutions have $1.54M invested in INVO Fertility Inc in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more capital invested

Capital invested by funds: $564K → $1.54M (+$977K)

0% more funds holding

Funds holding: 1010 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
1
Closed
3
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change

IVF Hedge Fund Activity: Q1 2023 in Review

10 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in INVO Fertility Inc (IVF) for Q1 2023, worth a combined $1.54M — up 173% from $564K a quarter earlier.

Fund positioning in IVF was balanced in Q1 2023: 3 funds opened new positions, 3 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $824K. The largest seller was Vanguard Group, cutting an estimated $155K.

  • 10 institutional investors held INVO Fertility Inc (IVF) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $1.54M of INVO Fertility Inc stock for Q1 2023, up 173% quarter-over-quarter.
  • 3 funds opened new INVO Fertility Inc positions in Q1 2023 and 3 closed out, a net change of 0 holders.
  • The largest INVO Fertility Inc buyer in Q1 2023 was Armistice Capital, an estimated $824K added.
  • The largest INVO Fertility Inc seller in Q1 2023 was Vanguard Group, an estimated $155K sold.

Based on aggregated 13F filings for Q1 2023.